seneca valley virus
Biologicalexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00314925)
Timeline
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- seneca valley virus
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06889493 | Phase 1 | May 19, 2025 | University of Miami |
| NCT01017601 | Phase 2 | Jan 1, 2010 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT01048892 | Phase 1 | Sep 1, 2009 | National Cancer Institute (NCI), University of Minnesota |
| NCT00314925 | Phase 1 | Apr 1, 2006 | Johns Hopkins University, Neotropix |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 2 | 2 | 2009 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Neotropix | For profit | 1 | 1 | 1 | 2006 |
| University of Miami | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Minnesota | Academic/Hospital | 1 | 0 | 1 | 2009 |
6 organizations
Page 1 / 1